Details for 2011850232
Up to date per 05.04.2026
Actions
Details for 2011850232
Granted/Registered
European Patent
30.10.2013 A
01.03.2017 B1
22.12.2010
US
201061425852 P
31.08.2011
US
201161529620 P
C07D 491/107 20060101AFI20140603BHEP
Owner
AstraZeneca AB 151 85 SödertäljeSE
Representative
Representative
HÄUPL & ELLMEYER KG PATENTANWALTSKANZLEI WIEN
Inventor
CSJERNYIK, GaborAstraZeneca R&D Södertälje SE-151 85 SödertäljeSE
KARLSTRÖM, SofiaAstraZeneca R&D Södertälje SE-151 85 SödertäljeSE
KERS, AnnikaAstraZeneca R&D Södertälje SE-151 85 SödertäljeSE
KOLMODIN, KarinAstraZeneca R&D Södertälje SE-151 85 SödertäljeSE
NYLÖF, MartinAstraZeneca R&D Södertälje SE-151 85 SödertäljeSE
ÖHBERG, LiselotteAstraZeneca R&D Södertälje SE-151 85 SödertäljeSE
RAKOS, LaszloAstraZeneca R&D Södertälje SE-151 85 SödertäljeSE
SANDBERG, LarsAstraZeneca R&D Södertälje SE-151 85 SödertäljeSE
SEHGELMEBLE, FernandoAstraZeneca R&D Södertälje SE-151 85 SödertäljeSE
SÖDERMAN, PeterAstraZeneca R&D Södertälje SE-151 85 SödertäljeSE
SWAHN, Britt-MarieAstraZeneca R&D Södertälje SE-151 85 SödertäljeSE
VON BERG, StefanAstraZeneca R&D Södertälje SE-151 85 SödertäljeSE
Information about Fees